The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients

Helicobacter

Volumn 2, Issue 2, 1997, Pages 86-91

  Takimoto, Takuya ^a   Satoh, Kiichi ^a   Taniguchi, Yushi ^a   Saifuku, Koji ^a   Kihira, Ken ^a   Seki, Masaru ^a   Yoshida, Yukio ^a   Ido, Kenichi ^a   Kimura, Ken ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; CLARITHROMYCIN; DRUG DERIVATIVE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; MIDDLE AGED;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE;

EID: 0031151627     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1997.tb00064.x     Document Type: Article

References (7)

1. Graham DY, Lew GM, Klein PD, Evans DG, Evans D Jr., Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
2. Labenz J, Börsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
3. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
4. Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 1994;12:1-23.
5. Labenz J, Gyenes E, Rühl GH, Börsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study. Gut 1993;34:1167-70.
6. Axon AT. Helicobacter pylori therapy: Effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6:131-7.
7. Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, Harrison G, Trowell JE. Experience with "triple" anu-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.